Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CoxaGenu AB
AB
Active
Org 5591057137
Ängslyckans Väg 4, 429 42
Särö
Medical specialists activities
· NACE 8622
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
CoxaGenu AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
566
396
385
275
380
Staff expenses
—
—
—
—
—
EBITDA
491
99
11
34
134
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
491
99
11
34
134
Net financials
−1
−1
−3
−1
−36
Profit before tax
491
98
9
34
98
Tax
−105
−20
−2
−7
−20
Net profit
386
78
7
27
78
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
972
732
563
490
356
Equity
663
558
369
295
144
Long-term debt
0
0
0
0
0
Short-term debt
308
174
194
194
212
Total debt
308
174
194
194
212
Financial ratios
5-year trend
EBITDA margin
35.3%
This company
15.8%
Market median
+123% vs market
2021
2025
Equity ratio
40.4%
This company
38.2%
Market median
+6% vs market
2021
2025
Return on equity
54.2%
This company
18.4%
Market median
+195% vs market
2021
2025
Net profit margin
20.5%
This company
8.1%
Market median
+153% vs market
2021
2025
Asset turnover
1.07×
This company
1.12×
Market median
+4% vs market
2021
2025
Debt / equity
1.47×
This company
0.62×
Market median
-137% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on CoxaGenu AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
